Improved dual specificity polypeptide molecule
JP2024023385A5Pending Publication Date: 2026-04-20IMMATICS BIOTECHNOLOGIES GMBH
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- IMMATICS BIOTECHNOLOGIES GMBH
- Filing Date
- 2023-11-24
- Publication Date
- 2026-04-20
Smart Images

Figure 00000035_0000 
Figure 00000035_0001 
Figure 00000035_0002
Abstract
To provide improved bispecific molecules capable of targeting peptide-MHC-complexes, that can be easily produced, display high stability and also provide high potency when binding to the respective antigen epitopes.SOLUTION: The present invention relates to a bispecific polypeptide molecule comprising a first polypeptide chain and a second polypeptide chain providing a binding region derived from a T cell receptor (TCR) being specific for a major histocompatibility complex (MHC)-associated peptide epitope, and a binding region derived from an antibody capable of recruiting human immune effector cells that specifically bind to a surface antigen of the cells, as well as methods of making the bispecific polypeptide molecule, and uses thereof.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art